Mahon Paul A

United Therapeutics Corp.

EVP & General Counsel

Avg. Two Year Performance

No Purchase Track Record

(27%) Avg. Sale Return (13%) Compound

Holdings: 36.71K shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drug Manufacturers - Other

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions